Noninvasive measurement of glucose through the optical properties of tissue
AssigneeSensys Medical, Inc.
InventorsTimothy L. Ruchti, Suresh N. Thennadil, Thomas B. Blank, Alexander Lorenz, Stephen L. Monfre
Life of this patent
Estimating the term…
Loading patent…
AssigneeSensys Medical, Inc.
InventorsTimothy L. Ruchti, Suresh N. Thennadil, Thomas B. Blank, Alexander Lorenz, Stephen L. Monfre
Estimating the term…
Methods and apparatus for noninvasive determination of blood analytes, such as glucose, through NIR spectroscopy utilize optical properties of tissue as reflected in key spectroscopic features to improve measurement accuracy and precision. Physiological conditions such as changes in water distribution among tissue compartments lead to complex alterations in the measured absorbance spectrum of skin and reflect a modification in the effective pathlength of light, leading to a biased noninvasive glucose measurement. Changes in the optical properties of tissue are detected by identifying key features responsive to physiological variations. Conditions not conducive to noninvasive measurement of glucose are detected. Noninvasive glucose measurements that are biased by physiological changes in tissue are compensated. In an alternate embodiment, glucose is measured indirectly based on natural physiological response of tissue to glucose concentration. A spectroscopic device capable of such measurements is provided.
A method for noninvasive measurement of a target analyte in a tissue sample, comprising the steps of:
An apparatus for noninvasive measurement of a target analyte in a tissue sample comprising:
A method for noninvasive measurement of a target analyte property in a tissue sample, comprising the steps of:
A method for noninvasive measurement of glucose concentration in a tissue sample, comprising the steps of:
A method for noninvasive measurement of a target analyte in a tissue sample, comprising the steps of:
Dependencies are inferred from the claim text.